Follow the 프롬바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 프롬바이오 has recorded 34 public disclosures. The latest transaction was filed on 2 July 2026 (Purchase). Among the most active insiders: 심태진. The full history is free.
30
Insider Decl.
n/a
Thresholds
n/a
17 ops.
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.